Skip to main content
Clinical Trials/JPRN-UMIN000048407
JPRN-UMIN000048407
Completed
N/A

A prospective observational study assessing patient preference for oral vs. injectable semaglutide in Japanese patients with type 2 diabetes using insulin and GLP-1 receptor agonists - Patient preference for oral vs. injectable semaglutide

Kanto Rosai Hospital0 sites65 target enrollmentJuly 20, 2022
Conditionstype 2 diabetes

Overview

Phase
N/A
Intervention
Not specified
Conditions
type 2 diabetes
Sponsor
Kanto Rosai Hospital
Enrollment
65
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 20, 2022
End Date
July 12, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) a history of hospitalization to improve glycemic control within the past 3 months 2\) considered to be ineligible for other reasons at the discretion of the attending physician.

Outcomes

Primary Outcomes

Not specified

Similar Trials